Firms

Founded

—

Type

Venture capital

Team

No team members on record yet.

Co-investing

ARCH Venture Partners

• City Therapeutics$99M · 2026-06-08
• Seaport Therapeutics$225M · 2024-10-21
• Rapport Therapeutics, Inc.$150M · 2023
• Mozart Therapeutics$55M · 2021-10-26
• Rapport$150M · Unknown date

T. Rowe Price

• Seaport Therapeutics$225M · 2024-10-21
• Rapport Therapeutics, Inc.$150M · 2023
• Rapport$150M · Unknown date

Bain Capital

• Aiolos Bio$245M · 2023-10-25
• Alkeus Pharmaceuticals$150M · Unknown date

Balderton Capital

• myTomorrows€10M · 2017-01-09
• myTomorrows€4M · Unknown date

Cormorant Asset Management

• Rapport Therapeutics, Inc.$150M · 2023
• Rapport$150M · Unknown date

SHOW MORE

Investments

$99M2026-06-08	City Therapeutics	ARCH Venture Partners, Casdin Capital, Viking Global Investors, Fidelity Investments, Sofinnova Partners, Rock Springs Capital, AN Venture Partners
$225M2024-10-21	Seaport Therapeutics	ARCH Venture Partners, T. Rowe Price, General Atlantic, Canada Pension Plan Investment Board, Sofinnova Partners, Third Rock Ventures
$245M2023-10-25	Aiolos Bio	Bain Capital, Atlas Venture, RA Capital Management, Forbion, Sofinnova Partners
$150M2023	Rapport Therapeutics, Inc.	ARCH Venture Partners, The Goldman Sachs Group, Inc., T. Rowe Price, Logos Capital, Cormorant Asset Management, Sofinnova Partners
$55M2021-10-26	Mozart Therapeutics	ARCH Venture Partners, MRL Ventures Fund, Leaps by Bayer, Alexandria Venture Investments, Altitude Life Science Ventures, Sofinnova Partners
€10M2017-01-09	myTomorrows	EQT Ventures, Octopus Ventures, Balderton Capital, Sofinnova Partners
$10M2001-10-24	Avaki	General Catalyst, Polaris Partners, Sofinnova Partners
$6M2001	Avaki	General Catalyst, Polaris Partners, Sofinnova Partners
€4MUnknown date	myTomorrows	Balderton Capital, Sofinnova Partners
$70MUnknown date	Excelsior Sciences	Khosla Ventures, Sofinnova Partners, Deerfield

SHOW MORE